Clinical Trial Update: Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the efficacy and safety of switching from cyclosporin to tacrolimus in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Renal Transplant Recipients | Phase 4 | Status: COMPLETED